Seeking AlphaTue, 24 Feb 2026 22:47:58 GMTProtara Therapeutics, Inc. (TARA) Discusses Interim Phase II Results for TARA-002 in Non-Muscle Invasive Bladder Cancer TranscriptTARA-1.86%